Israeli Cannabinoid Biotech Therapix IPOs on NASDAQ

Therapix Biosciences Ltd. Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing TEL AVIV, Israel, March 22, 2017 /PRNewswire/ — Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), a...
- March 22nd, 2017 at 3:14 pm

Aphria Graduates to Toronto Stock Exchange

Aphria Continues Success Story With TSX Listing Listing increases access to capital and growing investor base interested in burgeoning cannabis industry LEAMINGTON, ONTARIO–(Marketwired – March 21, 2017) – Aphria...
- March 21st, 2017 at 8:19 am

Emblem Exceeds 2000 Active Patients

Emblem Sees Significant Rise in Patient Acquisition PARIS, ONTARIO–(Marketwired – March 20, 2017) – Emblem Corp. (TSXV: EMC) (OTC: EMMBF) (“Emblem” or the “Company”) is pleased to announce that...
- March 20th, 2017 at 7:59 am

Nevada Medical Cannabis Patient Growth Bounces Back

After a two month pause in growth following the November elections, Nevada medical cannabis patient growth jumped by 4.1% in February to 26,519. This follows 0.3% growth in December...
- March 17th, 2017 at 11:43 am

Vyripharm Cannabis Testing Platform Issued Patent

Vyripharm Biopharmaceuticals Issued Patent for Comprehensive Medical Cannabis Testing from Agriculture to Clinical Applications Raising the Bar for Comprehensive Medical Cannabis and Hemp Testing and Evaluation HOUSTON, March 17,...
- March 17th, 2017 at 9:17 am

CanniMed Q1 Sales grow 8% from Q4

CanniMed Therapeutics Inc. Reports Financial Results for Q1 2017 March 16, 2017 SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (“CanniMed” or the “Company”) (TSX: CMED) (OTC: CMMDF) today released its financial...
- March 16th, 2017 at 11:36 pm

Jimi Hendrix Estate Sues Andrew Pitsicalis and Leon Hendrix

Hendrix Sues Serial Infringer Andrew Pitsicalis NEW YORK, March 16, 2017 /PRNewswire/ — Experience Hendrix, L.L.C. and Authentic Hendrix, LLC (“the Hendrix Companies”), the companies founded by the Estate...
- March 16th, 2017 at 2:54 pm